Brooks Moore & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Brooks Moore & Associates’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$211K	Hold	430	–	–	0.11%	105
2025 Q4	$249K	Sell	430 -15	-3%	-$8.48K	0.12%	98
2025 Q3	$216K	Hold	445	–	–	0.11%	101
2025 Q2	$208K	Hold	445	–	–	0.11%	103
2025 Q1	$221K	Sell	445 -25	-5%	-$13.5K	0.12%	101
2024 Q4	$245K	Hold	470	–	–	0.14%	89
2024 Q3	$291K	Hold	470	–	–	0.17%	81
2024 Q2	$260K	Hold	470	–	–	0.17%	81
2024 Q1	$273K	Sell	470 -11	-2%	-$6.17K	0.18%	81
2023 Q4	$255K	Buy	481 +11	+2%	+$5.32K	0.18%	82
2023 Q3	$238K	Hold	470	–	–	0.18%	77
2023 Q2	$245K	Hold	470	–	–	0.17%	77
2023 Q1	$271K	Sell	470 -25	-5%	-$14.1K	0.19%	74
2022 Q4	$273K	Hold	495	–	–	0.2%	76
2022 Q3	$251K	Hold	495	–	–	0.2%	70
2022 Q2	$269K	Hold	495	–	–	0.19%	75
2022 Q1	$292K	Hold	495	–	–	0.18%	84
2021 Q4	$330K	Hold	495	–	–	0.19%	82
2021 Q3	$283K	Hold	495	–	–	0.19%	85
2021 Q2	$250K	Hold	495	–	–	0.16%	92
2021 Q1	$226K	Hold	495	–	–	0.15%	92
2020 Q4	$231K	Hold	495	–	–	0.18%	87
2020 Q3	$219K	Sell	495 -75	-13%	-$31K	0.19%	79
2020 Q2	$207K	Buy	+570	New	+$191K	0.19%	80
2020 Q1	–	Sell	-620	Closed	-$201K	–	94
2019 Q4	$201K	Buy	+620	New	+$188K	0.16%	97

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brooks Moore & Associates's TMO Position: Q1 2026 in Review

Brooks Moore & Associates held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 430 shares worth $211K. The position accounts for 0.11% of the portfolio, ranked #105.

Brooks Moore & Associates first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $330K in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Brooks Moore & Associates held 430 shares of Thermo Fisher Scientific worth $211K as of Q1 2026.
Brooks Moore & Associates left its Thermo Fisher Scientific share count unchanged in Q1 2026.
Thermo Fisher Scientific made up 0.11% of Brooks Moore & Associates's portfolio in Q1 2026, its #105 holding.
Brooks Moore & Associates first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
Brooks Moore & Associates's Thermo Fisher Scientific position peaked at $330K in Q4 2021.
2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brooks Moore & Associates's 13F filing for Q1 2026, filed 15 May 2026.